TY  - ADVS
AU  - Marsh,Sharon
TI  - Pharmacogenomics in cancer therapy
T2  - Cancer genetics,
PY  - 2015///
CY  - London
PB  - Henry Stewart Talks
KW  - Antineoplastic agents
KW  - Cancer
KW  - Chemotherapy
KW  - Genetic aspects
KW  - Drugs
KW  - Side effects
KW  - Pharmacogenomics
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - therapeutic use
KW  - Camptothecin
KW  - analogs & derivatives
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Gene Expression Regulation, Neoplastic
KW  - Genetic Variation
KW  - Neoplasms
KW  - drug therapy
KW  - genetics
KW  - Pharmacogenetics
KW  - methods
KW  - Tamoxifen
KW  - pharmacokinetics
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics; Access restricted to subscribers
UR  - https://hstalks.com/bs/3139/
UR  - https://hstalks.com/bs/p/941/
ER  -